Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise

被引:47
|
作者
Birmingham, Daniel J. [1 ]
Merchant, Michael [2 ]
Waikar, Sushrut S. [3 ]
Nagaraja, Haikady [4 ]
Klein, Jon B. [2 ]
Rovin, Brad H. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Div Nephrol, 395 West 12th Ave,Ground Floor, Columbus, OH 43210 USA
[2] Univ Louisville, Sch Med, Louisville, KY 40292 USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
discovery and validation; longitudinal cohort; urine analyte; ERYTHROCYTE COMPLEMENT RECEPTORS; LABORATORY TESTS; URINE BIOMARKERS; ACTIVITY INDEX; RENAL FLARE; ERYTHEMATOSUS; KIDNEY; CR-1; INFLAMMATION; DISEASE;
D O I
10.1093/ndt/gfw300
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Biomarker development in lupus nephritis (LN) has traditionally relied on comparing the characteristics of candidate markers to clinical findings in patients and controls from cross-sectional cohorts. In this work, two additional strategies for LN biomarker development that are gaining ground will be discussed. One approach compares analytes directly to kidney histology. The second strategy utilizes longitudinal measurements of biomarker levels at regular intervals as patients move from disease quiescence to disease flare. These approaches have begun to empower biomarkers as diagnostic and prognostic tools in LN and have revealed novel and sometimes unexpected roles for these biomarkers in the pathogenesis and prediction of LN disease activity.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 50 条
  • [41] Novel Biomarkers for Lupus Nephritis in the "OMICS" Era
    Dias, Raphael
    Hasparyk, Ursula Gramiscelli
    Lopes, Monisi Peres
    de Barros, Joao Luiz Vieira Monteiro
    Simoes e Silva, Ana Cristina
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (29) : 6011 - 6044
  • [42] Metabolomics and biomarkers for lupus nephritis – a systematic review
    Felippe Pereira Barone
    Silvia Vanessa Lourenço
    Luiz Sergio Azevedo
    Mayara Nanci de Souza
    Claudia Malheiros Coutinho-Camillo
    Giovanna Piacenza Florezi
    Surgical and Experimental Pathology, 6 (1)
  • [43] Lupus Nephritis Risk Factors and Biomarkers: An Update
    Renaudineau, Yves
    Brooks, Wesley
    Belliere, Julie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [44] Urinary Biomarkers in Lupus Nephritis: Are We There Yet?
    Mok, Chi Chiu
    Mohan, Chandra
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (02) : 194 - 196
  • [45] Urine Biomarkers of Tubulointersitital Damage in Lupus Nephritis
    Lally, Brianna
    Wang, Shudan
    Chalmers, Sammy
    Mowrey, Wenzhu
    Rubinstein, Tamar
    Goilav, Beatrice
    Broder, Anna
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [46] Urine chemokines: biomarkers of human lupus nephritis?
    Ferri, G. M.
    Gigante, A.
    Ferri, E.
    Amoroso, D.
    Zardi, E.
    Papa, A.
    De Galasso, L.
    Amoroso, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2007, 11 (03) : 171 - 178
  • [47] Circulating exosomal microRNAs as biomarkers of lupus nephritis
    Chen, Fei
    Shi, Bo
    Liu, Wenjing
    Gong, Jianmin
    Gao, Jia
    Sun, Yifan
    Yang, Ping
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Care about the flare: the importance of avoiding lupus nephritis recurrence
    Weinmann-Menke, Julia
    Kraus, Daniel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (04) : 800 - 802
  • [49] Lupus nephritis flare in young patients: relapse or nonadherence to treatment?
    Rivera, Francisco
    Anaya, Sara
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2014, 7 : 117 - 121
  • [50] Direct medical cost 2 of renal flare in lupus nephritis
    Kalunian, Kenneth
    Ward, David
    Bramley, Tommy
    Juhasz, Marta
    Wiseman, Andrew
    Caviar, Niv
    Beitel, Jim
    Ginzler, Ellen M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S569 - S569